When did Biodexa Pharmaceuticals Plc go public?

Biodexa Pharmaceuticals Plc has already gone public and now trades publicly on Nasdaq under the ticker BDRX.

Can I buy Biodexa Pharmaceuticals Plc stock?

Yes — Biodexa Pharmaceuticals Plc is publicly traded on Nasdaq as BDRX. You can follow its live price, valuation and post-IPO performance above.

What is Biodexa Pharmaceuticals Plc's valuation?

Biodexa Pharmaceuticals Plc's most recent valuation tracked here is $1.47M, derived from live market prices.

All companies

Biodexa Pharmaceuticals Plc

BDRX

PublicArchived

Public / ArchivedUnited States(Nasdaq)Best valuation $1.47M1 market

Public listing

Listed· Nasdaq· Listing market: United States

Listing date

Not available

Offer price

Not available

Shares offered

Not available

Offering proceeds

Not available

Sources: sec-edgar, sec-harvest, nasdaq

IPO Calendar · NasdaqIPO

BDRX

Price

$0.3502

24h

-8.61%

Valuation

$1.47M

24h volume

$8.05M

Type

IPO

Trade Biodexa Pharmaceuticals Plc

Now trading publicly. Buy via a broker — opens in a new tab.

Trade on IPO Calendar

IPO Calendar · updated 2h ago

Biodexa Pharmaceuticals Plc IPO public float & lock-up

Public float and locked shares extracted from Biodexa Pharmaceuticals Plc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.

424B4Dec 19, 2025

Total shares (FD)

83.88B

Public float

—

Locked

—

IPO raise

—

Next unlock

—

Needs review: Could not extract a detailed lock-up release schedule.

SEC IPO filings

Final prospectus

EDGAR filings resolved from BDRX / CIK 0001643918.

424B3b928263424b3.htm

Oct 6, 2026Final prospectus0001214659-26-012602

EFFECTxslEFFECTX01/primary_doc.xml

Sep 30, 2026Effective9999999995-26-003123

F-1WARRANT INDUCEMENT

Sep 24, 2026Filed0001214659-26-011934

424B3bio424b3_333297473ps2.htm

Sep 15, 2026Final prospectus0001214659-26-011695

424B3bio424b3_333284350ps4.htm

Sep 15, 2026Final prospectus0001214659-26-011693

424B3bio424b3_333272693ps4.htm

Sep 15, 2026Final prospectus0001214659-26-011689

424B3bio424b3_333291598ps4.htm

Sep 15, 2026Final prospectus0001214659-26-011694

424B3bio424b3_333281489ps4.htm

Sep 15, 2026Final prospectus0001214659-26-011692

424B3bio424b3_333279994ps4.htm

Sep 15, 2026Final prospectus0001214659-26-011691

424B3bio424b3_333278040ps4.htm

Sep 15, 2026Final prospectus0001214659-26-011690

424B3bio424b3_333297473.htm

Sep 11, 2026Final prospectus0001214659-26-011637

424B3bio424b3_333281489.htm

Sep 11, 2026Final prospectus0001214659-26-011634

Biodexa Pharmaceuticals Plc IPO — frequently asked questions

When did Biodexa Pharmaceuticals Plc go public?: Biodexa Pharmaceuticals Plc has already gone public and now trades publicly on Nasdaq under the ticker BDRX.
Can I buy Biodexa Pharmaceuticals Plc stock?: Yes — Biodexa Pharmaceuticals Plc is publicly traded on Nasdaq as BDRX. You can follow its live price, valuation and post-IPO performance above.
What is Biodexa Pharmaceuticals Plc's valuation?: Biodexa Pharmaceuticals Plc's most recent valuation tracked here is $1.47M, derived from live market prices.